Evonik Industries (FRA:EVK) received a €38.70 ($46.07) target price from analysts at Warburg Research in a research report issued on Monday. The brokerage presently has a “buy” rating on the stock. Warburg Research’s target price would indicate a potential upside of 21.79% from the stock’s current price.
A number of other equities research analysts have also commented on EVK. J P Morgan Chase & Co set a €25.00 ($29.76) price objective on Evonik Industries and gave the stock a “sell” rating in a research report on Thursday, August 10th. Barclays set a €34.50 ($41.07) price objective on Evonik Industries and gave the stock a “buy” rating in a research report on Friday, September 29th. Kepler Capital Markets set a €31.00 ($36.90) price objective on Evonik Industries and gave the stock a “neutral” rating in a research report on Tuesday, November 28th. Credit Suisse Group set a €34.30 ($40.83) price objective on Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, September 26th. Finally, Deutsche Bank set a €32.00 ($38.10) price objective on Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, September 28th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eleven have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of €34.01 ($40.48).
Shares of Evonik Industries (EVK) opened at €31.78 ($37.83) on Monday. Evonik Industries has a 1 year low of €25.74 ($30.64) and a 1 year high of €32.97 ($39.25).
COPYRIGHT VIOLATION NOTICE: “Warburg Research Analysts Give Evonik Industries (EVK) a €38.70 Price Target” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/04/warburg-research-analysts-give-evonik-industries-evk-a-38-70-price-target.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with MarketBeat.com's FREE daily email newsletter.